Company intelligence / Profile preview

Novast Laboratories

Ownership: Private
Employees: ~52
Development stage: Commercial

Overview

Novast Laboratories is a China-based international pharmaceutical manufacturer specializing in high-quality generic and specialty drugs. It is notable for being the first Chinese company to gain US FDA approval for finished drug products sold in the US. The company has over 20 products launched commercially in the United States, with more than 100 pharmaceutical preparations developed or under certification by regulatory agencies[5][6].

Modalities: Small molecule
Industry: Biotech

Drug pipeline

4 assets

desipramine hydrochloride

Commercial

Indications: Depression

3 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Novast Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novast Laboratories.

Explore the full profile